...
search icon
hoth-img

Hoth Therapeutics Inc Share Price

HOTH
NAQ
$1.02
+$0.04
(4.08%)
1D
Industry: Pharmaceuticals Sector: Health Care

Hoth Therapeutics Inc Analyst Forecast

Hoth Therapeutics Inc Share Price Chart

Hoth Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$15.82M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
682.43K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.54
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.66 L
$2.12 H
$1.02

About Hoth Therapeutics Inc, Common Stock

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is headquartered in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Hoth Therapeutics Inc Stock Returns

Time FrameHOTHSectorS&P500
1-Week Return26.24%-0.03%-1.38%
1-Month Return-2.86%0.59%-1.81%
3-Month Return-13.56%3.23%1.38%
6-Month Return-21.54%18.29%5.68%
1-Year Return-4.67%7.71%11.74%
3-Year Return-61.65%18.03%65.15%
5-Year Return-98.36%35.78%73.68%
10-Year Return-99.52%140.42%260.03%

Hoth Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue25.87K46.87M66.83K--[{"date":"2020-12-31","value":0.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.14,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(25.87K)(46.87M)(66.83K)--[{"date":"2020-12-31","value":-2587100,"profit":false},{"date":"2021-12-31","value":-4687100000,"profit":false},{"date":"2022-12-31","value":-6683400,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses7.30M14.10M11.07M7.69M8.22M[{"date":"2020-12-31","value":51.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.47,"profit":true},{"date":"2023-12-31","value":54.55,"profit":true},{"date":"2024-12-31","value":58.26,"profit":true}]
Operating Income(7.30M)(14.10M)(11.07M)(7.69M)(8.22M)[{"date":"2020-12-31","value":-730197400,"profit":false},{"date":"2021-12-31","value":-1410144000,"profit":false},{"date":"2022-12-31","value":-1106555400,"profit":false},{"date":"2023-12-31","value":-769224200,"profit":false},{"date":"2024-12-31","value":-821543200,"profit":false}]
Total Non-Operating Income/Expense-(212.26K)(300.03K)(152.37K)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-21226500,"profit":false},{"date":"2022-12-31","value":-30002900,"profit":false},{"date":"2023-12-31","value":-15236700,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(7.20M)(14.31M)(11.37M)(7.85M)(8.19M)[{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1137195300,"profit":false},{"date":"2023-12-31","value":-784539000,"profit":false},{"date":"2024-12-31","value":-818830000,"profit":false}]
Income Taxes(205.25K)212.26K305.41K(7.69K)-[{"date":"2020-12-31","value":-67.21,"profit":false},{"date":"2021-12-31","value":69.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.52,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(14.53M)(11.68M)(7.84M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1452597000,"profit":false},{"date":"2022-12-31","value":-1167736200,"profit":false},{"date":"2023-12-31","value":-783769776,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(7.20M)(14.31M)(11.37M)(9.62M)(8.19M)[{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1137195300,"profit":false},{"date":"2023-12-31","value":-962174300,"profit":false},{"date":"2024-12-31","value":-818830000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(7.20M)(14.31M)(11.37M)(7.85M)(8.19M)[{"date":"2020-12-31","value":-719781600,"profit":false},{"date":"2021-12-31","value":-1431370500,"profit":false},{"date":"2022-12-31","value":-1137195300,"profit":false},{"date":"2023-12-31","value":-784539000,"profit":false},{"date":"2024-12-31","value":-818830000,"profit":false}]
EPS (Diluted)(14.50)(16.50)(9.91)(4.35)(1.33)[{"date":"2020-12-31","value":-1450,"profit":false},{"date":"2021-12-31","value":-1650,"profit":false},{"date":"2022-12-31","value":-991,"profit":false},{"date":"2023-12-31","value":-434.72,"profit":false},{"date":"2024-12-31","value":-133,"profit":false}]

Hoth Therapeutics Inc Ratios

Hoth Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

HOTH
Cash Ratio 7.75
Current Ratio 8.81

Hoth Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HOTH
ROA (LTM) -84.46%
ROE (LTM) -151.13%

Hoth Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HOTH
Debt Ratio Lower is generally better. Negative is bad. 0.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.89

Hoth Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HOTH
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.92
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.40

FAQs

What is Hoth Therapeutics Inc share price today?

Hoth Therapeutics Inc (HOTH) share price today is $1.02

Can Indians buy Hoth Therapeutics Inc shares?

Yes, Indians can buy shares of Hoth Therapeutics Inc (HOTH) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HOTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hoth Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Hoth Therapeutics Inc (HOTH) via the Vested app. You can start investing in Hoth Therapeutics Inc (HOTH) with a minimum investment of $1.

How to invest in Hoth Therapeutics Inc shares from India?

You can invest in shares of Hoth Therapeutics Inc (HOTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in HOTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hoth Therapeutics Inc shares
What is Hoth Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Hoth Therapeutics Inc (HOTH) is $2.12. The 52-week low price of Hoth Therapeutics Inc (HOTH) is $0.66.

What is Hoth Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Hoth Therapeutics Inc (HOTH) is

What is Hoth Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hoth Therapeutics Inc (HOTH) is 1.92

What is Hoth Therapeutics Inc dividend yield?

The dividend yield of Hoth Therapeutics Inc (HOTH) is 0.00%

What is the Market Cap of Hoth Therapeutics Inc?

The market capitalization of Hoth Therapeutics Inc (HOTH) is $15.82M

What is Hoth Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Hoth Therapeutics Inc is HOTH

How Can Investors Use Hoth Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Hoth Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Hoth Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Hoth Therapeutics Inc shares for Indian investors?

When investing in Hoth Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Hoth Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Hoth Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Hoth Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Hoth Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top